BAM
WST icon

Baring Asset Management’s West Pharmaceutical WST Stock Holding History

Baring Asset Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$1.56M Buy
16,214
+335
+2% +$30.3K 0.09% 117
2017
Q2 		$1.5M Sell
15,879
-143
-0.9% -$13.2K 0.1% 114
2017
Q1 		$1.31M Buy
16,022
+13,302
+489% +$1.11M 0.09% 136
2016
Q4 		$231K Buy
+2,720
New +$214K 0.02% 163

Other funds holding WST

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Baring Asset Management's WST Position: Q3 2017 in Review

Baring Asset Management increased its West Pharmaceutical (WST) stake by 2.1% in Q3 2017, buying an estimated $30.3K and bringing the position to 16,214 shares worth $1.56M. The position accounts for 0.09% of the portfolio, ranked #117.

Baring Asset Management first reported a position in WST in Q4 2016 and has held it in 4 quarters since. 302 funds tracked by Wall St. Rank hold WST as of Q3 2017.

  • Baring Asset Management held 16,214 shares of West Pharmaceutical worth $1.56M as of Q3 2017.
  • Baring Asset Management bought 335 West Pharmaceutical shares in Q3 2017, an estimated $30.3K.
  • West Pharmaceutical made up 0.09% of Baring Asset Management's portfolio in Q3 2017, its #117 holding.
  • Baring Asset Management first reported a position in West Pharmaceutical in Q4 2016 and has held it in 4 quarters since.
  • 302 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2017.

Based on Baring Asset Management's 13F filing for Q3 2017, filed 26 Oct 2017.